Skip to main content

Plant-Based Bioactive Compounds in Cancer Therapeutics

  • Chapter
  • First Online:
Prebiotics, Probiotics and Nutraceuticals

Abstract

Cancer is a dreadful disease, and it is considered as one of the biggest health problems for the human populations and demands an intense strategy to cure. Cancer causes around 70% death in lower- and middle-income countries. Recent studies have reported that natural bioactive compounds (obtained from medicinal plants) in combination with anticancer drugs have great potential to destroy cancerous cells while not affecting normal cells. Natural bioactive compounds are considered suitable candidates for anticancer drug development with the great success opportunity due to their excellent properties for modulating multiple cellular and molecular targets of oncogenesis directly or indirectly and have shown great progress past several decades. The chief anticancerous properties include the inhibition of tumor cell growth, the induction of apoptosis, DNA damage, the inhibition of topoisomerases I and II, and others. Nowadays, many researchers are on the way to develop potential drugs that can inhibit or delay the growth of tumor cells without any type of side effects from natural bioactive compounds. The chief plant-based bioactive compounds with potential cancer therapeutic potential include curcumin, camptothecin, diosgenin, epigallocatechin-3-gallate, homoharringtonine, piperine, podophyllotoxin, resveratrol, vinca alkaloids, etc.

This chapter provides a comprehensive report on the recent advancements and breakthrough accomplished in cancer treatments using natural bioactive compounds alone or in combination with other known therapies along with their possible mechanism of action on nuclear and cellular factors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

Download references

Acknowledgment

The authors extend their gratitude to the CSIR, New Delhi, for providing financial assistance in the form of CSIR-JRF to Neha Jain (File no. 09/149(0753)/2019-EMR-1).

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jain, N., Kaushik, P., Pareek, A., Pareek, H., Sharma, M.K. (2022). Plant-Based Bioactive Compounds in Cancer Therapeutics. In: Behera, K.K., Bist, R., Mohanty, S., Bhattacharya, M. (eds) Prebiotics, Probiotics and Nutraceuticals. Springer, Singapore. https://doi.org/10.1007/978-981-16-8990-1_3

Download citation

Publish with us

Policies and ethics